January 11, 2018
Sanofi reasonably filed a patent for its insulin injector in the FDA's Orange Book, since the agency wasn't clear about whether it should, and rationally defended that patent against possible infringement, a Massachusetts federal magistrate judge said Wednesday when dismissing an antitrust suit over the conduct.
September 26, 2017
Sanofi-Aventis urged a Massachusetts magistrate judge Tuesday to dismiss an antitrust suit over its Lantus diabetes treatments, arguing that it reasonably listed its products in the so-called Orange Book and that its patent litigation against Eli Lilly was not a sham.